Lung Cancer Equipment For Medical Specialties
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used to treat pleural mesothelioma and non-small-cell lung ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used as first-line therapy for ovarian cancer or breast cancer or lung ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used to treat breast cancer, non-small-cell lung cancer, prostate cancer, ovarian cancer, head and neck cancer, and esophageal ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used alone or in combination to treat ovarian cancer or breast cancer or lung ...
-
Manufactured by OTraces Inc.based in USA
BC Sera Dx Immunoassay test panel for detection of the presence of breast cancer in women. In the development pipeline are an Ovarian, OV Sera Dx, and Lung, LG Sera Dx, cancer detection test ...
-
Manufactured by INTERmedic Arfranbased in SPAIN
INTERmedic, worldwide leader in photodynamic therapy for pulmonology (lung cancer), gastroenterology (Barrett’s esophagus, esophageal cancer), urology (prostate cancer) among others, presents Multidiode™ PDT, an innovative technology to treat dermatological pathologies such as basal cell carcinoma, cholangiocarcinoma or hidradenitis ...
-
based in TAIWAN
TLC178 is our proprietary NanoX™ formulation of the anticancer drug vinorelbine, developed for the treatment of rhabdomyosarcoma (RMS), a rare form of soft tissue sarcoma that most frequently occurs in ...
-
Manufactured by OSE Immunotherapeuticsbased in FRANCE
Tedopi®, OSE Immunotherapeutics’s most advanced product and therapeutic neo-epitope-based vaccine, is a proprietary combination of nine optimized neo-epitopes, selected and optimized from 5 tumoral antigens to activate specifically T cells, plus one epitope giving universal helper T cell response targeting T cell ...
-
Manufactured by Eutilex Co.,Ltd.based in SOUTH KOREA
4th generation GPC3 CAR-T shows better efficacy compared to 2nd generation GPC3 CAR-T; Shows better efficacy for tumor clearance than 2nd generation GPC3 CAR-T in vivo; Clear anti-cancer efficacy in an orthotopic model; Smaller number of 4th generation GPC3 CAR-T required than other groups to remove ...
-
Manufactured by Elpisciencebased in CHINA
ES104 is a bispecific antibody that simultaneously blocks Delta-like ligand 4/Notch (DLL4) and vascular endothelial growth factor A (VEGF-A) signaling pathways, which are critical to angiogenesis and tumor vascularization. VEGF also plays an important role in creating an immune suppressive TME. Pre-clinical and early clinical data of ES104 show that blocking both pathways provides robust ...
-
Manufactured by Vitro Biopharmabased in USA
Human Lung Adenocarcinoma Cancer Associated Fibroblasts; Cryopreserved at a low passage; Stage: III; High passage capabilities; Expands in VitroPlusIII Low Serum, Complete Medium (Vitro Biopharma, Cat. No. PC00B1–optimized for high growth rates, reduced doubling times, healthy cells, and stability); Able to grow in low oxygen (1% - 5% O2); Available for research ...
-
Manufactured by Mersana Therapeuticsbased in USA
UpRi, a first-in-class ADC targeting the sodium-dependent phosphate transport protein NaPi2b, utilizes the Dolaflexin platform to deliver about 10 DolaLock payload molecules per antibody. The NaPi2b antigen is broadly expressed in ovarian cancer and non-small cell lung cancer (NSCLC) adenocarcinoma. UpRi is being studied in UPLIFT, a single-arm registration strategy, in patients with ...
-
Manufactured by Daiichi Sankyo Company Limitedbased in JAPAN
ENHERTU (5.4 mg/kg) is approved in more than 50 countries for the treatment of adult patients with unresectable or metastatic HER2 positive breast cancer who have received a (or one or more) prior antiHER2-based regimen, either in the metastatic setting or in the neoadjuvant or adjuvant setting, and have developed disease recurrence during or within six months of completing therapy based on the ...
-
based in SWITZERLAND
Avastin is a monoclonal antibody that targets vascular endothelial growth factor A (VEGF-A). With the initial approval in the United States for advanced colorectal cancer in 2004, Avastin became the first anti-angiogenic therapy made widely available for the treatment of patients with an advanced ...
-
Manufactured by Shanghai Henlius Biotech, Incbased in CHINA
(serplulimab injection, anti-PD-1 mAb), company’s first self-developed innovative monoclonal antibody, was approved by the NMPA for the treatment of Microsatellite Instability-High (MSI-H) solid tumors in March 2022, providing an alternative treatment option for patients with MSI-H solid tumors. Henlius actively promotes HANSIZHUANG in conjunction with in-house products of the company and ...
-
Manufactured by ScoutCam Ltdbased in ISRAEL
Pulmonary diagnostic centers, hospitals and clinics require both rigid and flexible bronchoscopes for diagnostics and pulmonary surgical procedures. According to medical device market data, the multi-million dollar overall bronchoscopes market is estimated to reach $868.7M by 2023, at a compound annual growth rate (CAGR) of 7.4 % in the US. Flexible bronchoscopes have the largest global market ...
-
Manufactured by STEMA Medizintechnik GmbHbased in GERMANY
Bronchoscopy is one of the most important examination methods for detection of diseases of the respiratory tract and lungs, especially if you suspect the presence of lung ...
-
Manufactured by Menssana Research Inc.based in USA
Every year in the U.S.A., 99,000 men and 78,000 women develop lung cancer, and only 14% of them are still alive five years later. Fortunately, early detection and treatment can reduce the number of deaths. Clinical studies at Menssana Research, Inc. have shown that breath biomarkers accurately identify lung cancer, and this has been confirmed in a blinded replicated ...
-
Manufactured by ViennaLab Diagnostics GmbHbased in AUSTRIA
NSCLC comprises approximately 85% of all lung cancers. Tumor specimens from patients should be tested for the presence of EGFR mutations prior to TKI treatment. The EGFR XL StripAssay® and EGFR T790M RealFast™ Assay are designed to assist clinicians in the stratification of patients considered for TKI ...
-
Manufactured by INOVIQ Ltdbased in AUSTRALIA
INOVIQ has three autoantibody tests in development for early detection of ovarian, breast and lung cancers. BARD1 autoantibody tests measure autoantibodies to variant BARD1 proteins in the blood and use a proprietary cancer-specific algorithm to combine these levels into a cancer score that identifies the presence or absence of a specific cancer. BARD1 autoantibodies reflect the body’s ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you